> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CURE ID Automating Data Collection
- URL: https://www.fdaweb.com/cure-id-automating-data-collection/
- Published: 2021-07-13T12:00:00.000Z
- Updated: 2026-09-14T17:06:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149698

CDER Office of Medical Policy health science policy analyst **Heather Stone** says the Office of Medical Policy Clinical Methodologies Group (ClinMeth) has made the CURE ID app more effective during the Covid-19 public health emergency. CURE ID allows healthcare providers to report new uses of existing drugs for 325 difficult-to-treat infectious diseases through a standardized simple case report form (CRF) from a Web site or mobile device.

In an online [post](https://www.fda.gov/drugs/news-events-human-drugs/cure-id-moves-automated-data-collection-light-covid-pandemic?ref=fdaweb.com), Stone says ClinMeth created a user-friendly CRF tailored to Covid-19 and included information on almost all clinical trials submitted to ClinicalTrials.gov for Covid-19 drugs, biologics, and vaccines as well as relevant journal articles, news articles and events, updating the information nearly daily.

“With so many healthcare specialists working on Covid-19,” Stone writes, “the ability to systematically capture and learn from other providers’ treatment experiences is invaluable.”

ClinMeth received a $9.2 million HHS grant 3/2021 to allow it to work with partners over the next two years to expand the open-access CURE ID platform of case reports to include anonymized electronic health record and registry data.